FREQUENCY OF HEPATITIC C VIRURS (HCV) GENOTYPES AND SUBTYPES
Main Article Content
Keywords
Adults, hepatitis C virus, genotypes, genotype 3
Abstract
Background: Viral hepatitis is still a major global public health concern; HCV is especially worrisome because it can develop chronic hepatitis that lasts a long time in vulnerable people. HCV is an encapsulated virus that was first discovered in 1989. It presents major clinical concerns as the second most common cause of viral hepatitis worldwide. Determining the HCV genotype is essential because treatment duration has been observed to differ according to genotype. While some genotypes react to treatment more quickly, others take longer to successfully eradicate the virus and achieve sustained virologic response (SVR). HCV infection is a major global health concern, because it is generally asymptomatic until clinical signs appear, it can be difficult to correctly estimate its incidence rate.
Objective: To assess the frequency of HCV genotypes and subtypes in people who are infected with hepatitis C Virus.
Study design: a cross sectional study
Place and Duration: This study was conducted at Khairpur Medical college teaching Hospital, Khairpur Mir's, Sindh, Pakistan from September 2022 to September 2023
Methodology: Participants in the study had to be 16 years of age or older and chronically infected with HCV. All the participants were positive for HCV RNA. These patients had 600 blood samples taken in order to ascertain their HCV genotypes. As directed by the Abbott Real Time HCV Genotype assay kit, RT-PCR was used for the genotyping analysis. Using fluorescent-labeled probes specific to each genotype, this kit detects the six major HCV genotypes (1-6) and their subtypes (1a and 1b). Primers target the 5'UTR region for genotypes 1-6 classification and the NS5B region for subtype detection of 1a and 1b.
Results: There were a total of 600 HCV positive samples assessed in this study subjected to genotyping. Out of 600 samples, 348 (58%) were males and 252 (42%) were females. This shows that the number of females in this research was lesser than males. The most frequent genotype was HCV genotype 3 affecting 85% of the total patients.
Conclusion: There were found to be eight genotypes and subtypes of hepatitis C virus, with genotype 3 being the most common.
References
2. Khan TM, Mehr MT, Ullah H, Khan H, Iman NU. Frequency of hepatitis C virus genotypes in the north of Pakistan. Gomal Journal of Medical Sciences. 2014 Sep 17;12(2).
3. Khan S, Ali I, Badshah M, Khan QM, Haider ZN, Ali S, Khan IA, Ullah A. Molecular epidemiology of hepatitis C virus genotypes among chronically infected patients in Pakistan. Jundishapur Journal of Microbiology. 2019 Mar 31;12(3).
4. Waqar M, Khan AU, Rehman HU, Idrees M, Wasim M, Ali A, Niaz Z, Ismail Z, Rehman MU, Tariq M, Shah M. Determination of hepatitis C virus genotypes circulating in different districts of Punjab (Pakistan). European journal of gastroenterology & hepatology. 2014 Jan 1;26(1):59-64.
5. Butt S, Idrees M, Akbar H, ur Rehman I, Awan Z, Afzal S, Hussain A, Shahid M, Manzoor S, Rafique S. The changing epidemiology pattern and frequency distribution of hepatitis C virus in Pakistan. Infection, Genetics and Evolution. 2010 Jul 1;10(5):595-600.
6. Khan N, Akmal M, Hayat M, Umar M, Ullah A, Ahmed I, Rahim K, Ali S, Bahadar S, Saleha S. Geographic distribution of hepatitis C virus genotypes in pakistan. Hepatitis monthly. 2014 Oct;14(10).
7. Inamullah I, Idrees M, Ahmed H, Ali M, Ali L, Ahmed A. Hepatitis C virus genotypes circulating in district Swat of Khyber Pakhtoonkhaw, Pakistan. Virology Journal. 2011 Dec;8:1-5.
8. Ali A, Ahmed H, Idrees M. Molecular epidemiology of Hepatitis C virus genotypes in Khyber Pakhtoonkhaw of Pakistan. Virology journal. 2010 Dec;7:1-7.
9. Attaullah S, Khan S, Ali I. Hepatitis C virus genotypes in Pakistan: a systemic review. Virology journal. 2011 Dec;8:1-6.
10. Narahari S, Juwle A, Basak S, Saranath D. Prevalence and geographic distribution of Hepatitis C Virus genotypes in Indian patient cohort. Infection, Genetics and Evolution. 2009 Jul 1;9(4):643-5.
11. Heathcote EJ (2007). Antiviral therapy: chronic hepatitis C. J Viral Hepat 1482-88.
12. Rosen HR (2011). Chronic Hepatitis C Infection. N Engl J Med 364(25): 2429- 2438.
13. Sy T & Jamal MM (2006). Epidemiology of hepatitis C virus (HCV) infection. Int J Med Sci 3(2): 41-6
14. Afridi S, Zahid MN, Shabbir MZ, Hussain Z, Mukhtar N, Tipu MY, Akhtar F & Yaqub T (2013). Prevalence of HCV genotypes in district Mardan. Virol J 10(1): 90.
15. Ahmad W, Ijaz B, Javed FT, Jahan S, Shahid I, Khan FM & Hassan S (2010). HCV genotype distribution and possible transmission risks in Lahore, Pakistan. World J of Gastroenterol WJG 16(34): 4321.
16. Afridi S, Naeem M, Hussain A, Kakar N, Babar ME & Ahmad J (2009). Prevalence of hepatitis C virus (HCV) genotypes in Balochistan. Mol Bio Rep 36(6): 1511-1514.
17. Singh B, Verma M & Verma K (2004). Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends. Japanese J of Infec Dis 57(2): 49-51.
18. Rouabhia S, Sadelaoud M, ChaabnaMokrane K, Toumi W & Abenavoli L (2013). Hepatitis C virus genotypes in north eastern Algeria: A retrospective study. World J of Hepatol 5(7): 393.
19. Anwar MI, Rahman M, Hassan MU & Iqbal M (2013). Prevalence of active hepatitis C virus infections among general public of Lahore, Pakistan. Virol J 10(1): 351.
20. Waheed Y (2015). Effect of interferon plus ribavirin therapy on hepatitis C virus genotype 3 patients from Pakistan: treatment response, side effects and future prospective. Asian Pacific J of Trop Med 8(2): 85-89.